Understanding how certain immune cells can prevent allergic reactions in the lungs
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
This study is looking at how certain immune cells called Treg cells help manage allergies like asthma by learning to ignore harmless things in the environment, and it hopes to find new ways to make these cells work better, which could lead to new treatments for people with allergic airway issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11074570 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells, known as Treg cells, in controlling allergic airway diseases like asthma. It focuses on how these cells develop tolerance to harmless substances in the environment and how their function can be influenced by changes in cellular metabolism. By studying the interactions between transcription factors and metabolic regulators, the research aims to uncover new mechanisms that could enhance the ability of Treg cells to suppress allergic responses. This could lead to innovative therapies for patients suffering from allergic airway diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with allergic airway diseases, such as asthma, particularly those who experience severe allergic reactions.
Not a fit: Patients with non-allergic respiratory conditions or those who do not have allergic airway diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the management of allergic airway diseases, potentially reducing symptoms and improving quality of life for patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune cells in allergic responses, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Yang, Kai — Indiana University Indianapolis
- Study coordinator: Yang, Kai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.